2020Faculty Opinions – Post-Publication Peer Review of the Biomedical LiteratureOpen access

Faculty Opinions recommendation of EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

Roberto Arenas, Eder Rodrigo Juárez-Durán

Open full text 0 citations

Abstract

Read the full review for this Faculty Opinions recommended article: EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

Open-access reader

About this research paper

What this paper is about

Read the full review for this Faculty Opinions recommended article: EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Read the full review for this Faculty Opinions recommended article: EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

Key concepts: Leishmania tropica, Cutaneous leishmaniasis, Imiquimod, Leishmania, Leishmania major, In vitro, Leishmaniasis, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Faculty Opinions recommendation of EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica. — Research Paper | ScholarLens